ADMA Biologics Inc (ADMA) Q4 2025 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Adma Biologics Inc.

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:00.031 -- 00:00:05.438 Good afternoon, and welcome to the ADMA Biologics Full Year 2025 Financial 00:00:05.438 -- 00:00:11.664 Results and Business Update Conference Call on Wednesday, February 25, 2026. 00:00:12.428 -- 00:00:15.672 At this time, all participants are in a listen-only mode. 00:00:15.672 -- 00:00:18.396 There will be a question-and-answer session to follow. 00:00:18.396 -- 00:00:23.483 Please be advised that this call is being recorded at the company's request and 00:00:23.483 -- 00:00:27.829 will be available on the company's website approximately two hours following the end 00:00:27.829 -- 00:00:31.622 of the call. At this time, I would like to introduce the company. 00:00:31.622 -- 00:00:34.303 Please go ahead. 00:00:36.208 -- 00:00:40.594 Welcome, everyone, and thank you for joining us this afternoon to discuss Adma Biologics' 00:00:40.594 -- 00:00:45.600 financial results for the fourth quarter and full year 2025 and recent corporate 00:00:45.600 -- 00:00:51.427 updates. I'm joined today by Adam Grossman, our President and Chief Executive Officer, 00:00:51.427 -- 00:00:57.389 Brad Tade, our Retiring CFO and Treasurer, and Terry Kohler, our Incoming CFO and Treasurer. 00:00:57.389 -- 00:01:01.855 During today's call, Adam will provide some introductory comments and provide an update 00:01:01.855 -- 00:01:06.260 on corporate progress. Brad will then provide an overview of the company's fourth quarter 00:01:06.260 -- 00:01:11.868 and full year 2025 financial results, and Terry will make some introductory comments. 00:01:11.868 -- 00:01:15.873 Finally, Adam will then provide some brief summary remarks before opening up the call 00:01:15.873 -- 00:01:21.540 for questions. Earlier today, we issued a press release detailing the full year 202...